EFFECTS OF DOXAZOSIN ON ATHEROSCLEROSIS IN CHOLESTEROL-FED RABBITS

被引:12
作者
SWINDELL, AC
KRUPP, MN
TWOMEY, TM
REYNOLDS, JA
CHICHESTER, CO
机构
[1] UNIV RHODE ISL,DEPT PHARMACOL & TOXICOL,KINGSTON,RI 02881
[2] BRISTOL MYERS,SYRACUSE,NY 13221
关键词
DOXAZOSIN; ALPHA(1)-ADRENERGIC INHIBITION; CHOLESTEROL-FED RABBIT; ATHEROSCLEROSIS; AORTA;
D O I
10.1016/0021-9150(93)90022-M
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Doxazosin was administered to rabbits fed diets enriched in cholesterol and peanut oil for 7.5 or 12 weeks, in 2 separate experiments. Doxazosin suppressed the accumulation of cholesterol and formation of atherosclerotic plaques in the aortas of treated rabbits and prevented a diet-induced increase in aortic collagen and wall mass. Doxazosin was more effective in the thoracic and abdominal segments of the aorta than in the aortic arch. Pharmacokinetic analysis indicated that treated rabbits were exposed to concentrations of doxazosin, integrated over 24 h, which were consistent with the therapeutic range of doxazosin measured in patients treated for hypertension. Doxazosin did not alter serum levels of cholesterol or triglycerides, nor were there any consistent effects on glucose, free fatty acid or ketone levels. Hypotheses of the mechanism of action of doxazosin are discussed, including the possible involvement of alpha1-adrenergic receptors in recruitment of smooth muscle cells by subintimal macrophages and nonadrenergic mechanisms of inhibition of lipid infiltration.
引用
收藏
页码:195 / 206
页数:12
相关论文
共 98 条
[1]   THE EFFECT OF PLATELETS ON MACROPHAGE LIPOPROTEIN METABOLISM [J].
AVIRAM, M .
ATHEROSCLEROSIS, 1988, 73 (2-3) :269-271
[2]   ANTI-INFLAMMATORY DRUGS IN EXPERIMENTAL ATHEROSCLEROSIS .5. INFLUENCE OF CORTISONE-ACETATE ON SHORT-TERM AND LONG-TERM CHOLESTEROL FLUXES IN ATHEROSCLEROTIC AORTA [J].
BAILEY, JM ;
WATSON, R ;
BOMBARD, AT ;
RANDAZZO, R .
ATHEROSCLEROSIS, 1984, 51 (2-3) :299-306
[3]  
BEITZ J, 1991, BIOMED BIOCHIM ACTA, V50, P101
[4]   MECHANISM OF PROTECTION FROM ATHEROSCLEROSIS BY VERAPAMIL IN THE CHOLESTEROL-FED RABBIT [J].
BLUMLEIN, SL ;
SIEVERS, R ;
KIDD, P ;
PARMLEY, WW .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 54 (07) :884-889
[6]   RELATIONSHIP OF AN ABNORMAL PLASMA-LIPOPROTEIN TO PROTECTION FROM ATHEROSCLEROSIS IN THE CHOLESTEROL-FED DIABETIC RABBIT [J].
BRECHER, P ;
CHOBANIAN, AV ;
SMALL, DM ;
VANSICKLE, W ;
TERCYAK, A ;
LAZZARI, A ;
BALER, J .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (05) :1553-1562
[8]   DEMONSTRATION THAT CIRCULATING HUMAN-BLOOD CELLS HAVE NO DETECTABLE ALPHA-1-ADRENERGIC RECEPTORS BY RADIOLIGAND BINDING ANALYSIS [J].
CASALE, TB ;
KALINER, M .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1984, 74 (06) :812-818
[9]   SUPPRESSION OF CALCIFIC FIBROUS-FATTY PLAQUE-FORMATION IN RABBITS BY AGENTS NOT AFFECTING ELEVATED SERUM-CHOLESTEROL LEVELS - EFFECT OF THIOPHENE COMPOUNDS [J].
CHAN, CT ;
WELLS, H ;
KRAMSCH, DM .
CIRCULATION RESEARCH, 1978, 43 (01) :115-125
[10]  
CHICHESTER CO, 1987, J CARDIOVASC PHARM, V10, pS21